We showed that upregulation of ARHGEF15 in pancreatic cancer increased activation of the Rho-family proteins, especially RhoA, Cdc42 and Rac, resulting in enhanced motility of the pancreatic cancer cells. The gene discussed is CDC42; the disease is pancreatic neoplasm.